|
May 8
|
Q1 2024 Bioventus Inc Earnings Call
|
|
May 7
|
Bioventus Reports First Quarter Financial Results
|
|
Apr 29
|
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
|
|
Mar 13
|
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript
|
|
Mar 13
|
Q4 2023 Bioventus Inc Earnings Call
|
|
Mar 12
|
Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ...
|
|
Mar 12
|
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
|
|
Mar 4
|
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
|
|
Jan 12
|
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
|
|
Dec 6
|
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
|
|
Nov 27
|
Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant
|
|
May 23
|
Bioventus Completes Divestiture of its Wound Business
|